About
Non-surgical, self-administered treatment for HPV-induced neoplasia/cancer
Areas of Focus
Categories
Midwest
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
233
By Phase
PHASE2: 4PHASE1: 3
By Status
RECRUITING: 3COMPLETED: 3ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06206564Lead Sponsor
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
PHASE2Recruiting
48 participants
Started: Jan 12, 2024 · Completed: Dec 31, 2026
NCT06075264Lead Sponsor
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
PHASE2Recruiting
27 participants
Started: Dec 6, 2023 · Completed: Dec 31, 2027
NCT05555862Lead Sponsor
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL
PHASE2Active, not recruiting
17 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2026
NCT04098744Lead Sponsor
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
PHASE2Recruiting
78 participants
Started: Sep 9, 2020 · Completed: Dec 31, 2026
NCT03792516Collaborator
Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)
PHASE1Completed
15 participants
Started: Apr 17, 2019 · Completed: Dec 3, 2024
Locations (1)
Headquarters
Mentor, OH, United States
Map
Loading map...